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INTRODUCTION
Intestinal microbiota is the set of microorganisms (bacteria, 
fungi, archaea, protozoa, and viruses) present inside the gut; 
mammals’ guts contain roughly 1010-1014 microorganisms. 
Bacteria are of fundamental importance because they help 
maintain gut homeostasis by competing with pathogens, 
by regulating energy metabolism and also producing im-
munomodulatory substrates such as short-chain fatty acids 
(i.e. acetate, propionate, butyrate). Firmicutes, Bacteroidetes, 
Proteobacteria, Fusobacteria, and Actinobacteria are the 
most common ones (around 99%); the composition differs 
between species.(7,23)
Shifts in microbial communities are due to disease, drug 
administration, diet, etc., and in recent years, the study of 
gut microbiome (DNA-based techniques) has better defined/
characterized this relationship in many cases.
Diet and dysbiosis
With regard to diet, evidence demonstrates that it could 
(variably) influence microbiome composition. A recent study 
in dogs showed that fiber supplementation (beet pulp), for 
a fourteen-day period, modified the Firmicutes:Fusobacteria 
ratio with an increase of the former.(15) Nevertheless, the 
administration of a fiber enriched diet in eighteen dogs 
did not significantly alter the fecal bacterial populations in 
the previous study of Simpson et al.,(20) although the fecal 
concentration of ammonia, sulfide and indole decreased, as 
did the fecal pH, while concentrations of acetic, propionic, 
and butyric acid increased.(20) Also potato fiber supplementa-
SUMMARY
Microbiome, diet, gastrointestinal disease and dysbiosis
Intestinal microbiota is the set of microorganisms (bacteria, fungi, archaea, protozoa, and viruses) present inside the gut; bac-
teria are of fundamental importance because they help maintain gut homeostasis by competing with pathogens, by regulating 
energy metabolism and also producing immunomodulatory substrates such as short-chain fatty acids (i.e. acetate, propion-
ate, butyrate). Shifts in microbial communities are due to disease, drug administration, diet, etc., and in recent years, the 
study of gut microbiome (DNA-based techniques) has better defined/characterized this relationship in many cases. The link 
between microbiome (dysbiosis) and health and disease is very complex and still far to be completely understood. We wanted 
to underline the importance of diet in modulating gut microbiome, possibly a useful tool also in term of disease prevention, and 
of microbial-microbial signaling. Even more we wanted to stress that it will be fundamental to better characterize dysbiosis, 
cause this may guide treatment decisions.
KEY WORDS 
fecal microbiome, diet, dysbiosis, microbial signaling
tion altered the Firmicutes:Fusobacteria ratio, leading to an 
increase of Firmicutes and a decrease of Fusobacteria; such 
a fiber also showed probiotic potential due to the increased 
proportion of Faecalibacterium and fecal short-chain fatty 
acid concentration.(17) Similarly, the increase of protein and/
or carbohydrates in a diet was also able to modify the fecal 
microbiome. More precisely, it has been shown that high-
protein and high-carbohydrate diets, both lead to a reduction 
of bacterial diversity and of Clostridium cluster XIVa (fam. 
Lachnospiraceae), while the higher protein level led to an 
increase of order Fusobacteriales, while carbohydrates 
increased the Clostridium cluster XVIII (order Erysipelot-
richales).(6) A recent study also showed the importance of 
a raw meat-based diet in modifying the gut microbiome, 
with a reduction of Fusobacteria and Proteobacteria and 
of Faecalibacterium, Lactobacillus, and Prevotella.(2) The 
influence of diet on the microbial population has also been 
recently studied in cats. A first study showed that even in 
the absence of significant changes, the administration of 
diets supplemented with 4% cellulose, or fructooligosac-
charides (FOS), or pectin led to a higher percentage of Ac-
tinobacteria in the FOS group than in the other two groups, 
and to higher percentages of Firmicutes and Proteobacteria 
in the pectin group, where total bacteria also increased.(1) 
Subsequently, the effect of a high-protein low-carbohydrate 
diet was also tested in cats (kittens) and, if compared to 
a moderate-protein moderate-carbohydrate diet, the former 
diet resulted in a higher percentage of Actinobacteria (also 
Clostridium, Faecalibacterium, Ruminococcus, and Blautia 
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were higher), and a lower percentage of Fusobacteria, with 
more Bifidobacterium present if fed on the latter diet.(8) 
Finally, a raw meat diet has also been tested in cats; in the 
study, a chicken-based extruded diet and raw whole chicks 
were administered to cats, resulting in higher percentages 
of Faecalibacterium and Recently, it has also been hy-
pothesized that the different consistency of the diets (dry 
vs wet), with two slightly different macronutrient profile 
diets, resulted in higher percentages of Actinobacteria and 
Lactobacillus, and lower percentages of Fusobacteria and 
Proteobacteria in cats fed the dry diet.(3) Succinivibrio in 
animals fed on the former diet (extruded), while cats fed the 
raw diet presented with higher percentages of unidentified 
Lachnospiraceae, Peptococcus and Pseudobutyrivibrio. 
Interestingly, Lactobacillus and Bifidobacterium were not 
found in the feces of cats fed raw diet.(11)
Dysbiosis and Gastrointestinal (GI) disease
A very important question is whether, and to what extent, 
the dysbiosis is the cause or the effect of the GI disease 
and, consequently, how to interpret a dysbiosis. It is well 
known that GI diseases are variably associated with dysbio-
sis. A recent study showed important differences between 
the fecal microbiome of healthy dogs, dogs with acute 
non-hemorrhagic, and acute hemorrhagic diarrhea, and dogs 
with controlled and uncontrolled IBD; interestingly, during 
diarrhea potentially positive bacteria that are producers of 
short-chain fatty acid are commonly decreased.(22) However, 
only few studies showed a direct link between dysbiosis and 
GI disease. In TNFdeltaARE mice (a model for CD-like [Crohn’s 
disease] ileitis) it has been shown that the transplantation of 
disease associated microbiota led to CD-like ileitis in genetic 
susceptible mice housed under germ-free conditions, and the 
severity of the ileitis appeared associated with compositional 
and functional dysbiosis.(19) Similarly, it was also shown that 
the dysbiosis associated with IBD could lead to an altered 
bile acids (BA) metabolism, with a decrease of secondary 
BA, that in some cases showed an in vitro anti-inflammatory 
activity, suggesting that the dysbiosis could be associated 
with an increased inflammatory response in IBD patients.(5) 
Dysbiosis: the concept of “quorum sensing” abrogation 
and internecine production in GI disease 
Within a prokaryotic species, secretion of soluble chemicals 
is used by individual bacterial cells to communicate with 
one another, inducing coordinated gene regulation when 
environmental conditions are appropriate (quorum sensing). 
A subset of these small diffusible molecules that mediate 
intraspecies signaling can be perceived by other strains of 
bacteria, allowing interspecies communication. Thus, the 
normal microbiota produces a carefully balanced combina-
tion of interspecific and intraspecific chemical signals that 
could suppress pathogenic invaders, as well as optimize the 
composition and numbers of appropriate members of the 
microbiota. A dysbiotic microbiota might also involve some 
degree of internecine dysfunction, a deleterious combination 
of chemical signals that disorder the microbiotal community 
structure. A dysbiotic microbiota is an ecological disorder of 
the bacterial community; the concept is often associated with 
the pathogenesis of IBD.(18,21) Germ-free mice have increased 
susceptibility to a variety of enteric pathogens, an obser-
vation that led to the concept of “colonization resistance”.
(25) This presumptive role of the microbiota in suppressing 
encounters with overt pathogens is likely multifactorial. The 
normal microbiota may compete for access to adhesive 
sites on the epithelial surface or stimulate increased mucin 
production. SCFAs may be bacteriostatic for a subset of 
bacterial species, either directly or by reducing pH. Some 
members of the microbiota also generate bacteriocins, small 
peptide molecules with microbicidal or microbistatic proper-
ties.(4) In addition, there is increasing interest in the effects 
of microbial-microbial signaling on the overall equilibrium of 
optimal microbiotal ecosystems.(10)
The mammalian gut is equipped with both innate and adap-
tive immunity to tolerate a “correct” microbiota and realize 
its benefits, maintaining surveillance over the microbiota 
and controlling its number and composition. The detailed 
mechanisms by which host non-adaptive immunity moni-
tors and responds to the presence of microbes has been 
extensively reviewed.(9,14) The immune system, broadly 
defined, is entrusted to modulate bacterial numbers and 
perhaps diversity, whereas the resident prokaryotes have 
their own means to deliberately modify host processes. This 
mutual crosstalk often involves reciprocal manipulation of 
growth, survival, and inflammatory controls and is another 
dimension of the gut microbe relationship, which when 
disturbed can result in a spectrum of intestinal disorders. 
The general paradigm holds that the gut is equipped with 
pattern recognition receptors (PRRs), an operational term for 
transmembrane or intracytoplasmic receptors that are defined 
by the ability to specifically recognize and bind distinctive 
microbial macromolecular ligands designated as microbial-
associated molecular patterns (MAMPs). PRRs include the 
trans-membrane Toll-like receptors (TLRs), which scan the 
extracellular space, whereas the Nod-like receptors (NLRs) 
guard the intracellular cytoplasmic compartment. Nonpatho-
genic prokaryotes, including natural commensals and those 
with proposed probiotic function, are able to suppress eu-
karyotic inflammatory signaling pathways and inflammatory 
effector functions; these suppressive effects are mediated 
either by intact viable organisms or by secreted products.(12)
An additional facet of the “negotiated settlement” that oc-
curs between host and microbe is adaptive immunity, only 
present in vertebrates, specifically the gut/mucosal arm 
of the adaptive immune system, which provides humoral 
and cell-mediated immunity against ingested antigens and 
luminal organisms. Adaptive immunity features the selective 
ability to respond to or ignore individual, specific antigens 
based on past encounters. Thus, the mucosal immune 
system can develop tolerance to ingested (or gut resident) 
antigens; repeat or continual exposure to the same stimulus 
does not elicit the immune response that it does in a naive 
animal. The occasional dysregulation of this arrangement, 
such as during the pathogenesis of IBD and perhaps other 
immune and metabolic disorders, may be the price paid for 
an extended metabolic ability (and other still uncharacterized 
benefits) provided by a normal microbiota.
Stimulation of immune development can be mediated via 
recognition of bacterial capsular polysaccharides. A specific 
polysaccharide (polysaccharide A) product of B fragilis has 
been identified that is recognized by dendritic cells and serves 
to stimulate development of regulatory T lymphocytes (Tregs) 
with the ability to attenuate pathogen- or chemical-induced 
colitis.(13) These data indicate that specific carbohydrate moi-
eties on symbiotic bacteria can initiate suppressive regulatory 
effects on effector lymphocytes. This cytoprotective effect 
of a bacterial product acts via the adaptive immune system, 
rather than the more ancient PRR-based innate/inflammatory 
signaling and cellular cytoprotective pathways.
A microbiota in ecological collapse could permit emergence 
of autochthonous bacteria that blur the distinction between 
symbiont and pathogen, exemplified by Clostridia difficile 
proliferation following vancomycin treatment, which can re-
sult in pseudomembranous colitis.(16,24) Together, these data 
illustrate the important role of the microbiota in protection 
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from enteric pathogens and the compositional and functional 
concept of dysbiosis in causing the GI tract pathology.
CONCLUSIONI
The link between microbiome (dysbiosis) and health and 
disease is very complex and still far to be completely 
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understood, but growing evidences reveal pieces of this 
puzzle. We wanted to underline the importance of diet in 
modulating gut microbiome, possibly a useful tool also in 
term of disease prevention, and even more to stress that it 
will be fundamental to better characterize dysbiosis, cause 
this may guide treatment decisions.
